2Ferenci P, I.ockwood A, Mullen K, et al. Hepatic eneephalopa thy definition, nomenclature, diagnosis, and quantification: fina report of the working party al the 11^th World Congresses of Gas troenterology, Vienna, 1998, Hepatology, 2002, 35:710-721.
3Laccetti M, Manes G, Uomo G, et al. Flumazenilin the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study. Dig Liver Dis, 21100. 32: 335-338.
4Als-Nielsen B, Gluud LL, Gluud C, et al. Non absorbable disaccharides for hepalic encephalopathy: systemic review of randomized trims. BMJ, 2004, 328(7447): 1046.
5Mullen KD, Ferenci P, Bass NM, et al. An algortithm for man agement of hepatic encephalopathy. Strain Liver Dis, 2007:32-48.
8Arguedas MR, DeLawrenceTG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in paticrus with cirrhosis. Dis DisSci, 2003, 45: 1622-1626.
6Whorwell PJ, Altinger L, Morel J, et al. Efficacy of an encap- sulated probiotic bifidobacterium infantis 35624 in women with irritable bowel syndrome [ J]. Am J Gastroenterol , 2006, 101 : 1581 - 1590.
7Guyonnet D, Chassany O, Ducrotte P, et al. Effect of a fer -mented milk containing bifidobacterium animalis DN - 173 010 on the health - related quality of life and symptomsin irri2table bowel syndrome in adults in primary care: a multicentre, randomized, double - blind, controlled trial [J]. Aliment Pharmacol Ther,2007 ,26:475 - 486.
8Petrof EO, Ko -jima K, Ropeleski M J, et al. Probiotics inhibit nuclearfactor2kappaB and induce heat shockpro- teins in colonic epithelial cells through proteasome inhi- bition[J]. Gastroenterology, 2004, 127 (5) : 1474-1487.
9Gotteland M, Brunser C. Systematic review:are probiotics useful in controlling gastric colonization by helicobacter pylori [ J ] ? Aliment pharmacol Ther, 2006,23 : 1077 - 1086.
10Sleator RD, Hill C. New frontiers in probiotic research [ J ]. Lett Appl Microbiol, 2008, 46 (2) : 143 - 147.
